Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 6,650,000 shares, an increase of 27.6% from the November 30th total of 5,210,000 shares. Based on an average daily volume of 777,800 shares, […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 6,650,000 shares, a growth of 27.6% from the November 30th total of 5,210,000 shares. Based on an average daily volume of 777,800 shares, […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned an average recommendation of “Buy” from the six research firms that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price objective among analysts that have covered the stock in the […]
Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) traded up 8.3% during trading on Wednesday . The company traded as high as $17.20 and last traded at $17.20. 34,407 shares changed hands during trading, a decline of 88% from the average session volume of 288,567 shares. The stock had previously closed at $15.88. […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned a consensus recommendation of “Buy” from the six research firms that are covering the company, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have issued ratings on the stock in the last year […]